Related Experiment Video
Updated: Oct 1, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 10, 2014
Correction of HIV-associated thrombocytopenia with low doses of interferon alfa
K P Murphy1, M D Stein, R P D'Amico
1Brown University Program in Medicine, Rhode Island Hospital, Providence 02903.
Abstract:
We have presented a case of HIV-associated thrombocytopenia successfully treated with low dose interferon alfa-2a. Increases in platelet levels were achieved within 1 week without hospitalization or surgery. Further, the patient had no systemic side effects from therapy. Zidovudine alone was ineffective in maintaining noncritical platelet counts. Interferon alfa-2a is a nonimmunosuppressive, nonsurgical therapy that can correct HIV-associated thrombocytopenia without requiring hospitalization.
Related Concept Videos
Retrovirus Life Cycles
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Inhibitors of Viral Protein Synthesis

